Suraksha Diagnostics Limited IPO, which started its subscription on last Friday, will go on up to December 3, 2024 and the applicant has two days more to make their application.
The issue price of this IPO is set within the price band of ₹420 – ₹441 per equity share. This public issue through an offer for sale amounting to ₹846.25 crore, shall add no direct funds into the balance sheet of the company. Proceeds from the IPO will go to the promoters selling their stake in the company.
Suraksha Diagnostics specializes in medical consultancy services, hoping to attract investors in the rising healthcare sector. At the time of writing on the second day of subscription at December 2, 2024 at 1:02 pm, the IPO received an overall subscriptions of 0.20 times. The retail segment was subscribed 0.36 times. The NII category subscribed 0.09 times.
Suraksha Diagnostics IPO: An opportunity for investors to invest in the healthcare sector due to the rising demand for diagnostic services in India.
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.